Financialsexperimental
FIRST KEYSTONE CORP (FKYS). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands
| Cash Flow | Q2 FY26 30 Jun 2026 | Q1 FY26 31 Mar 2026 | Q4 FY25 31 Dec 2025 | Q3 FY25 30 Sept 2025 | Q2 FY25 30 Jun 2025 | Q1 FY25 31 Mar 2025 | Q4 FY24 31 Dec 2024 | Q3 FY24 30 Sept 2024 | Q2 FY24 30 Jun 2024 | Q1 FY24 31 Mar 2024 | Q4 FY23 31 Dec 2023 | Q3 FY23 30 Sept 2023 | Q2 FY23 30 Jun 2023 | Q1 FY23 31 Mar 2023 | Q4 FY22 31 Dec 2022 | Q3 FY22 30 Sept 2022 | Q2 FY22 30 Jun 2022 | Q1 FY22 31 Mar 2022 | Q4 FY21 31 Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 3,155,000* | 3,504,000* | 3,822,000* | 3,543,000 | 3,182,000* | ||||||||||||||
| Net income | 3,777* | 1,959 | -623* | 2,808* | 2,914* | 1,053 | 2,287* | 1,507* | 1,380* | -18,377 | 1,781* | 1,283* | 1,139* | 1,357 | |||||
| (Credit) provision for loan losses | -920,000* | 219,000* | 218,000* | 219,000 | 405,000* | ||||||||||||||
| (Release of) provision for credit losses on loans | -299* | -390 | 3,932* | 255* | -237* | 751 | 148* | 718* | 510* | 264 | 119* | -370* | 34* | 0 | |||||
| Release of credit losses on unfunded commitments | -59* | 54 | -8* | -6* | 7* | -13 | -70* | -23* | 9* | 20 | -66* | -28* | |||||||
| Depreciation and amortization | 316* | 348 | 334* | 334* | 340* | 269 | 220* | 173* | 275* | 278 | 85* | 173* | 287* | 253 | 264* | 264* | 267* | 261 | 263* |
| Goodwill impairment | 0* | 0* | 0* | 0 | 0* | 0* | 0* | 19,133,000 | |||||||||||
| Net (discount accretion) premium amortization on securities | -65* | -48 | -81* | ||||||||||||||||
| Deferred income tax expense | 77* | 34 | -646* | 42* | 315* | -105 | -17* | 315* | -24* | -333 | 135* | 84* | 40* | -6 | 278* | -139* | -66* | 41 | -10* |
| Net premium amortization on securities | 54,000* | 50,000 | -3,000* | -9,000* | 34,000* | 251,000 | 323,000* | 397,000* | 399,000* | 400,000 | 662,000* | 713,000* | 795,000* | 838,000 | 806,000* | ||||
| Net gains on sales of mortgage loans | -13* | -46 | -46* | -59* | -18* | -20 | -12* | -40* | -17* | -11 | -21* | -10* | -17* | -17 | -31* | 4* | -0* | 34 | -179* |
| Proceeds from sales of mortgage loans originated for sale | 637* | 1,948 | 1,924* | 1,871* | 872* | 1,049 | 558* | 1,250* | 1,136* | 463 | 745* | 643* | 670* | 451 | 1,252* | -3* | 0* | 4,429 | 5,901* |
| Common stock issued | 399,000* | 10,000* | 410,000* | 445,000 | 446,000* | 452,000* | |||||||||||||
| Originations of mortgage loans originated for sale | -1,660* | -1,215 | -2,917* | -1,813* | -401* | -857 | -858* | -1,333* | -1,314* | -348 | -936* | -634* | -538* | -478 | -601* | -1,177* | -2,867* | -3,201 | -5,922* |
| Net securities gains | -374* | -174 | -96* | -109* | -105* | 86 | -153* | -146* | 10* | 184 | -94* | 87* | 69* | 56 | 665* | 50* | 68* | 63 | -158* |
| Decrease in accrued interest receivable | 180* | 153 | 78* | -121* | 115* | -76 | 266* | 69* | -37* | -90 | -586* | -442* | -138* | 356 | 88* | -6* | -152* | 40 | -78* |
| Increase in cash surrender value of bank owned life insurance | -174* | -170 | -174* | -172* | -155* | -165 | -171* | -172* | -164* | -162 | -162* | -157* | -153* | -149 | -150* | -151* | -148* | -148 | -150* |
| Gain from bank-owned life insurance proceeds | 0* | 0 | 0* | 0* | 20* | 235 | |||||||||||||
| Net losses on disposals of premises and equipment | 5* | 10* | 2* | -0 | 12* | -0* | -0* | 2 | 8* | 9* | -0* | 2 | 5* | 1* | 2* | 8 | 1* | ||
| (Increase) decrease in other assets | 1,395* | -1,583 | 678* | -610* | 2,250* | -1,734 | -535* | -478* | 701* | -500 | 661* | 87* | 619* | -706 | -257* | 554* | 16* | -655 | -132* |
| Amortization of investment in low-income housing partnerships | 205* | 204 | 205* | 205* | 195* | 214 | 205* | 205* | 204* | 205 | 73* | 52* | 53* | 53 | 52* | 53* | 52* | 68 | 93* |
| (Decrease) increase in accrued interest payable | -163* | -55 | -440* | 856* | -219* | 386 | -438* | -1,108* | 589* | 286 | 1,163* | 489* | -118* | 726 | -10* | 300* | -233* | 255 | -289* |
| Increase (decrease) in other liabilities | -1,071* | 1,176 | -157* | 84* | -488* | -345 | -1,099* | 957* | -216* | 338 | -581* | 340* | -63* | -5,125 | 684* | -400* | 384* | -347 | 261* |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 2,713* | 2,195 | 1,968* | 3,466* | 5,421* | 308 | 739* | 1,895* | 3,486* | 2,048 | 3,093* | 2,455* | 3,184* | -2,827 | 5,136* | 3,786* | 2,158* | 5,448 | 3,994* |
| Proceeds from maturities and redemptions of debt securities available-for-sale | 18,390* | 10,543 | 16,544* | 14,949* | 13,761* | 13,126 | 13,129* | 14,231* | 20,528* | 21,990 | 12,553* | 11,160* | 9,562* | 8,425 | 15,543* | 7,529* | 14,236* | 14,635 | 12,344* |
| Proceeds from sales of equity securities and debt securities available-for-sale | 0* | 0* | 0* | 0 | 0* | 0* | 0* | 23,230,000 | 58,675,000* | 0* | 0* | ||||||||
| Purchases of debt securities available-for-sale | -0* | -4,000 | -0* | -49,418* | -2,500* | -0 | -4,020* | -3,000* | -19,315* | -39,124 | -62,423* | -19,040* | -0* | -0 | -53,169* | -0* | -4,010* | -34,314 | -19,616* |
| Net (increase) decrease in restricted investment in bank stocks | -35* | -0 | -0* | -0* | 391* | -351 | 1,781* | 728* | -543* | -65 | -3,868* | 1,600* | -265* | -1,216 | -2,728* | 1,345* | -2,704* | -1,130 | 385* |
| Net increase in loans originated as held for investment | -16,640* | 15,139 | 2,021* | 3,889* | -16,257 | -13,673* | -12,730* | -12,847* | 1,510 | -29,839* | -9,768* | -9,190* | -3,683 | -13,431* | -39,847* | -22,920* | -27,411 | 4,131* | |
| Net decrease in time deposits with other banks | 0* | 0* | 0* | 0 | 0* | 0* | 0* | 247,000 | |||||||||||
| Proceeds from bank-owned life insurance | 0* | 0 | 1* | 0* | 8* | 1,229 | |||||||||||||
| Purchase of premises and equipment | -130* | -84 | 16* | -62* | -126* | -141 | -304* | -848* | -130* | -446 | -214* | -191* | -383* | -868 | -1,447* | -120* | -228* | -97 | -184* |
| Purchase of investment in real estate venture | 0 | 0* | 0* | -10* | 10 | 0* | 0* | 10* | 0 | 49* | 532* | 721* | 1,113 | 910* | 903* | ||||
| NET CASH PROVIDED BY INVESTING ACTIVITIES | 1,585* | 21,598 | 24,388* | -32,510* | 15,433* | -2,404 | -3,087* | -1,619* | -12,317* | -16,135 | -83,840* | -16,771* | -997* | 24,775 | 2,533* | -31,996* | -16,101* | -48,070 | -3,375* |
| Proceeds from sales of foreclosed assets held for resale | 0* | ||||||||||||||||||
| Net increase in deposits | 48,621* | -6,148 | -55,057* | 135,216* | 11,885* | -487 | 25,971* | 35,700* | 2,558* | 1,212 | -11,864* | 56,462* | -12,074* | -45,584 | -64,810* | 64,701* | -51,869* | -32,492 | -67,535* |
| Net decrease in short-term borrowings | -480* | -761 | 3,989* | 3,305* | -10,737* | 5,862 | -33,049* | -7,836* | 9,026* | 12,817 | -1,308* | -38,583* | 13,452* | 26,489 | 58,670* | -34,975* | 77,392* | 24,954 | -2,476* |
| Dividends paid, net of reinvestment | -1,317* | -1,294 | -1,294* | ||||||||||||||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 46,824* | -8,203 | -52,362* | 137,246* | -593* | 3,634 | -4,422* | 7,477* | 9,861* | 12,315 | 85,123* | 13,178* | -725* | -20,373 | -7,411* | 28,466* | 14,268* | -8,817 | -71,329* |
| INCREASE IN CASH AND CASH EQUIVALENTS | 51,122* | 15,590 | -26,006* | 108,202* | 20,261* | 1,538 | -6,770* | 7,753* | 1,030* | -1,772 | 4,376* | -1,138* | 1,462* | 1,575 | 258* | 256* | 325* | -51,439 | -70,710* |
| Repayment of finance lease obligations | 0* | 0* | 0* | 0 | 0* | 2,000* | 3,000* | 2,000 | 3,000* | 2,000* | 3,000* | 2,000 | 3,000* | ||||||
| Common stock issued | 0* | 0 | 409,000 | 413,000* | 417,000* | 417,000* | 388,000 | 405,000* | |||||||||||
| CASH AND CASH EQUIVALENTS, BEGINNING | 136,839* | 121,249 | 17,254* | 17,254* | 18,792* | 17,254 | 24,024* | 16,271* | 15,241* | 17,013 | 12,637* | 13,775* | 12,313* | 10,738 | 10,480* | 10,224* | 9,899* | 61,338 | |
| Dividends paid | -1,714,000 | -1,705,000* | -1,699,000* | -1,691,000* | -1,685,000 | -1,681,000* | -1,675,000* | -1,669,000* | -1,665,000 | -1,720,000* | |||||||||
| Repayment of long-term borrowings | 0* | 0* | 0* | 3,000,000* | 0* | 0* | 0* | ||||||||||||
| Dividends paid | -1,741,000* | -1,741,000 | -1,344,000* | -387,000* | |||||||||||||||
| CASH AND CASH EQUIVALENTS, ENDING | 187,961 | 136,839 | 121,249 | 17,254 | 17,254 | 18,792 | 17,254 | 24,024 | 16,271 | 15,241 | 17,013 | 12,637 | 13,775 | 12,313 | 10,738 | 10,480 | 10,224 | 9,899 | 61,338 |
| CASH AND CASH EQUIVALENTS, BEGINNING | 132,048,000* | ||||||||||||||||||
| Interest paid | 9,823* | 10,166 | 10,913* | 9,399* | 9,599* | 9,054 | 11,279* | 11,196* | 9,003* | 9,185 | 7,310* | 6,864* | 6,661* | 4,777 | 4,042* | 2,078* | 1,563* | 918 | 1,561* |
| Income taxes paid | 0* | 3 | 305* | 368* | 316* | -106 | -19* | 11* | 24* | 85* | 803* | 537* | 540* | ||||||
| Right-of-use assets obtained in exchange for lease liabilities | 0* | 34 | 0* | 0* | 4* | 29 | 0* | 0* | 0* | 33 | 0* | 0* | 0* | 33 | |||||
| Common stock subscription receivable | 0* | 0 | 0* | -10,000* | -6,000* | 16,000 | -2,000* | 3,000* | 0* | 13,000 | -8,000* | 2,000* | -2,000* | 16,000 | -6,000* | ||||
| Purchased securities settling after year-end | -2,262,000* | ||||||||||||||||||
| Right-of-use assets obtained in exchange for lease liabilities | 0* | 0* | 35,000 | ||||||||||||||||
| Loans transferred from held for sale to held for investment portfolio | 0* | 0* | 0* | 1,248,000* |